CD44 and neoplasm: In vivo assays with an orthotopic xenograft model proved that chloroquine plus paclitaxel significantly reduced tumor growth and CD44+/CD24−/low population, as opposed to paclitaxel alone, which had no effect on tumor growth and increased the CD44+/CD24−/low population, compared to controls, in accordance with previous in vitro assays [146].